Stay updated with breaking news from Tom Graney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special
Investegate announcements from Oxurion NV, Oxurion Issues EUR 2.0 million in Bonds for Tranche 1 (B) of the Funding Program with Atlas Special Opportunities LLC
Leuven, BELGIUM, Boston, MA, US - April 27, 2023 - 7:00 pm CET - Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies,
Leuven, BELGIUM, Boston, MA, US – April 27, 2023 – 7:00 pm CET – Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with... | June 18, 2023
Investegate announcements from Oxurion NV, Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC